IgD Antibody (IGHD/6818R) [DyLight 594]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-20992DL594
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
DyLight 594 (Excitation = 593 nm, Emission = 618 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Kappa Clone # IGHD/6818R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for IgD Antibody (IGHD/6818R) [DyLight 594]
Immunogen
Recombinant fragment (around aa1-200) of human IgD protein (exact sequence is proprietary)
Localization
Cytoplasm.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG Kappa
Applications for IgD Antibody (IGHD/6818R) [DyLight 594]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: IgD
Long Name
Immunoglobulin D
Alternate Names
Igh-5, Ighd, Immunoglobulin Delta
Gene Symbol
IGHD
Additional IgD Products
Product Documents for IgD Antibody (IGHD/6818R) [DyLight 594]
Product Specific Notices for IgD Antibody (IGHD/6818R) [DyLight 594]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...